#PrecisionMedicine Archives

AASLD Exclusive Interview with Dr. Grace Lai-Hung Wong: Quantitative HBsAg – A New Perspective in Advancing Hepatitis B Management and Functional Cure

By Peng Longmei 2024.12.27

With significant progress in hepatitis B treatment, particularly in the pursuit of a functional cure, the quantification of hepatitis B surface antigen (HBsAg) has emerged as a critical factor in…

AASLD 2024丨Dr. Jinlin Hou’s Team: Cost-Effectiveness of aMAP Score-Guided Individualized HCC Screening in HBsAg-Positive Populations

By El Bachir MOURABIT 2024.12.02

Hepatocellular carcinoma (HCC) imposes a significant health and economic burden on patients. Screening, recognized as an effective strategy to improve early diagnosis rates in high-risk populations, has garnered broad acknowledgment…

AASLD Exclusive Interview | Dr.Mark Yarchoan: Progress in the Treatment of Intermediate and Advanced HCC, Highlighting the Value of Systemic Therapy

By El Bachir MOURABIT 2024.01.16

Editor's Note: At the recently concluded international annual flagship event in the field of hepatology – the American Association for the Study of Liver Diseases Annual Meeting (AASLD 2023), Professor…

Dr. Nigel Russell: The Latest International Treatment Advances in Acute Myeloid Leukemia

By Mourabit Halima 2024.01.14

Abstract: Dr. Nigel Russell provides insights into the recent developments in the treatment landscape of Acute Myeloid Leukemia (AML). The discussion encompasses the combination of FLT3 mutation inhibitors with intensive…